Latest News about PFE
Recent news which mentions PFE
3 Volatility-Busting, Low-Beta Stocks to Grab Now
March 03, 2024
From InvestorPlace
Tickers
PFE
From Motley Fool
Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?
March 02, 2024
From InvestorPlace
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
From Motley Fool
3 Overhyped Stocks Every Smart Investor Should Ignore
March 01, 2024
From InvestorPlace
Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds
February 29, 2024
From Benzinga
3 Starter Long-Term Stocks Every New Investor Should Own
February 28, 2024
From InvestorPlace
3 Forgotten Dividend Stocks With a Yield of Over 5%
February 28, 2024
From InvestorPlace
7 Dividend Stocks to Buy to Secure Steady Income
February 28, 2024
From InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
From InvestorPlace
Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst
February 27, 2024
Tickers
PFE
From Motley Fool
7 Defensive Stocks to Weather Any Downturn With Ease
February 26, 2024
From InvestorPlace
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
From InvestorPlace
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
From InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
From Benzinga
From Benzinga
7 Struggling Stocks to Sell Before Q2 2024
February 26, 2024
From InvestorPlace
From Motley Fool
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
From InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $50
February 23, 2024
From Motley Fool
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
From Benzinga
7 Stocks to Buy for Bargain Hunters on the Prowl
February 22, 2024
From InvestorPlace
Better Bull Market Buy: Novavax vs. Pfizer
February 22, 2024
From Motley Fool
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
From Benzinga
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
February 21, 2024
From Motley Fool
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
From InvestorPlace
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.